HLA antigens and immunoglobulin allotypes in patients with malignant melanoma

J. P. Pandey; A. H. Johnson; H. H. Fudenberg; D. B. Amos; J. U. Gutterman; E. M. Hersh

doi:10.1016/0198-8859(81)90010-0

HLA antigens and immunoglobulin allotypes in patients with malignant melanoma

J. P. Pandey, A. H. Johnson, H. H. Fudenberg, D. B. Amos, J. U. Gutterman, E. M. Hersh

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

HLA antigens and Gm, A2m, and Km allotypes were examined in Caucasian patients with malignant melanoma. No significant associations were found for any of the HLA antigens tested. Significant association was found with Gm(2), and the relative risk for individuals with this marker was calculated at 1.9. The data indicate that Caucasians positive for Gm(2) are almost twice as likely to develop malignant melanoma as those without this marker.

Original language	English (US)
Pages (from-to)	185-190
Number of pages	6
Journal	Human Immunology
Volume	2
Issue number	3
DOIs	https://doi.org/10.1016/0198-8859(81)90010-0
State	Published - May 1981
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/0198-8859(81)90010-0

Cite this

@article{db05ac62ba47450aac2b17465602ce82,

title = "HLA antigens and immunoglobulin allotypes in patients with malignant melanoma",

abstract = "HLA antigens and Gm, A2m, and Km allotypes were examined in Caucasian patients with malignant melanoma. No significant associations were found for any of the HLA antigens tested. Significant association was found with Gm(2), and the relative risk for individuals with this marker was calculated at 1.9. The data indicate that Caucasians positive for Gm(2) are almost twice as likely to develop malignant melanoma as those without this marker.",

author = "Pandey, {J. P.} and Johnson, {A. H.} and Fudenberg, {H. H.} and Amos, {D. B.} and Gutterman, {J. U.} and Hersh, {E. M.}",

note = "Funding Information: ACKNOWLEDGMENT We thank Charles L. Smith for editorial assistance, and Beth Phifer and Vennie Mo~re for technical assist'~nce. Research was supported in part by USPHS Grants HD-09938 and CA-25746. This is publication No. 379 from the Department oi~{"} Basic and C\[in/cai Immunology and Microbiology, Medical University of South Carolina.",

year = "1981",

month = may,

doi = "10.1016/0198-8859(81)90010-0",

language = "English (US)",

volume = "2",

pages = "185--190",

journal = "Human Immunology",

issn = "0198-8859",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - HLA antigens and immunoglobulin allotypes in patients with malignant melanoma

AU - Pandey, J. P.

AU - Johnson, A. H.

AU - Fudenberg, H. H.

AU - Amos, D. B.

AU - Gutterman, J. U.

AU - Hersh, E. M.

N1 - Funding Information: ACKNOWLEDGMENT We thank Charles L. Smith for editorial assistance, and Beth Phifer and Vennie Mo~re for technical assist'~nce. Research was supported in part by USPHS Grants HD-09938 and CA-25746. This is publication No. 379 from the Department oi~" Basic and C\[in/cai Immunology and Microbiology, Medical University of South Carolina.

PY - 1981/5

Y1 - 1981/5

N2 - HLA antigens and Gm, A2m, and Km allotypes were examined in Caucasian patients with malignant melanoma. No significant associations were found for any of the HLA antigens tested. Significant association was found with Gm(2), and the relative risk for individuals with this marker was calculated at 1.9. The data indicate that Caucasians positive for Gm(2) are almost twice as likely to develop malignant melanoma as those without this marker.

AB - HLA antigens and Gm, A2m, and Km allotypes were examined in Caucasian patients with malignant melanoma. No significant associations were found for any of the HLA antigens tested. Significant association was found with Gm(2), and the relative risk for individuals with this marker was calculated at 1.9. The data indicate that Caucasians positive for Gm(2) are almost twice as likely to develop malignant melanoma as those without this marker.

UR - http://www.scopus.com/inward/record.url?scp=0019865189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019865189&partnerID=8YFLogxK

U2 - 10.1016/0198-8859(81)90010-0

DO - 10.1016/0198-8859(81)90010-0

M3 - Article

C2 - 7263315

AN - SCOPUS:0019865189

SN - 0198-8859

VL - 2

SP - 185

EP - 190

JO - Human Immunology

JF - Human Immunology

IS - 3

ER -

HLA antigens and immunoglobulin allotypes in patients with malignant melanoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this